[
    [
        {
            "time": "2019-01-15",
            "original_text": "上海新兴血液制品疑染艾滋 业内人事:混合投浆追溯难",
            "features": {
                "keywords": [
                    "上海新兴",
                    "血液制品",
                    "艾滋病",
                    "混合投浆",
                    "追溯难"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海新兴血液制品疑染艾滋 业内人事:混合投浆追溯难",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-16",
            "original_text": "国家卫健委出手！回应血液制品艾滋病抗体阳性事件",
            "features": {
                "keywords": [
                    "国家卫健委",
                    "艾滋病抗体阳性",
                    "血液制品"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "公共卫生"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国家卫健委出手！回应血液制品艾滋病抗体阳性事件",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-17",
            "original_text": "上海新兴产品发现艾滋抗体阳性 专家组抵江西调查",
            "features": {
                "keywords": [
                    "上海新兴",
                    "艾滋病抗体阳性",
                    "专家组",
                    "调查"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海新兴产品发现艾滋抗体阳性 专家组抵江西调查",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-18",
            "original_text": "【独家】上海新兴医药静注人免疫球蛋白尚未立案 同批次原料的其他血液产品未检测出艾滋病阳性",
            "features": {
                "keywords": [
                    "上海新兴",
                    "静注人免疫球蛋白",
                    "立案",
                    "同批次原料",
                    "艾滋病阳性"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【独家】上海新兴医药静注人免疫球蛋白尚未立案 同批次原料的其他血液产品未检测出艾滋病阳性",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]